Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07312669 · ClinicalTrials.gov registry record
ROP Check Database Premature Infant Outcomes
A clinical trial of Retinopathy of Prematurity (ROP), sponsored by Alaska Blind Child Discovery.
- Completed
- Registry status
- 7,070
- Enrollment target
- 1
- Study location
NCT07312669 is a study of Retinopathy of Prematurity (ROP) that has completed, run by Alaska Blind Child Discovery. The registered enrollment target is 7,070 participants, above the 203-participant average among 3 other Retinopathy of Prematurity (ROP) trials with a reported enrollment target (3383% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07312669, a study of Retinopathy of Prematurity (ROP), has completed, sponsored by Alaska Blind Child Discovery.
- COMPLETED
- Registry status
- 7,070 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observation of multi-centered care of infants covered by ROP Check cloud-based database is to compare demographic and clinical risk factors to evaluate and improve vision-protecting guidelines.
Conditions Studied
Study Locations (1)
Alaska
- Alaska Children's EYE & Strabismus - Anchorage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,070 participants |
| Start Date | 2010-01-01 |
| Est. Completion | 2022-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07312669
The ClinicalTrials.gov registry entry for NCT07312669 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7,070 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 203-participant average among 3 other Retinopathy of Prematurity (ROP) trials with a reported enrollment target (3383% higher). The listed sponsor is Alaska Blind Child Discovery, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Retinopathy of Prematurity (ROP) appearing as the primary indexed condition, and to 0 interventions.
NCT07312669 reports 1 study location spanning 1 distinct geographic area - top geographies include Alaska.
Frequently Asked Questions
What is clinical trial NCT07312669 about?
NCT07312669 is a clinical study titled "ROP Check Database Premature Infant Outcomes". The goal of this observation of multi-centered care of infants covered by ROP Check cloud-based database is to compare demographic and clinical risk factors to evaluate and improve vision-protecting guidelines.
What is the current status of trial NCT07312669?
This trial is currently completed. The enrollment target is 7,070 participants. The study started on 2010-01-01. Estimated completion is 2022-12-31.
What conditions does trial NCT07312669 study?
This clinical trial studies the following conditions: Retinopathy of Prematurity (ROP).
Who is sponsoring clinical trial NCT07312669?
This trial is sponsored by Alaska Blind Child Discovery, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07312669 being conducted?
This trial has 1 study location across Alaska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinopathy of Prematurity (ROP)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.